These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29414125)

  • 1. A mesoporous silica based platform to enable tablet formulations of low dose drugs by direct compression.
    Sun WJ; Aburub A; Sun CC
    Int J Pharm; 2018 Mar; 539(1-2):184-189. PubMed ID: 29414125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression.
    Sun WJ; Aburub A; Sun CC
    J Pharm Sci; 2017 Jul; 106(7):1772-1777. PubMed ID: 28322940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manufacturing of Multi-drug Formulations with Customised Dose by Solvent Impregnation of Mesoporous Silica Tablets.
    Šoltys M; Akhlasová S; Zadražil A; Kovačík P; Štěpánek F
    AAPS PharmSciTech; 2019 Jan; 20(1):25. PubMed ID: 30604137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable and Fast-Dissolving Amorphous Drug Composites Preparation via Impregnation of Neusilin
    Azad M; Moreno J; Davé R
    J Pharm Sci; 2018 Jan; 107(1):170-182. PubMed ID: 29031953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enabling direct compression tablet formulation of celecoxib by simultaneously eliminating punch sticking, improving manufacturability, and enhancing dissolution through co-processing with a mesoporous carrier.
    Paul S; Guo Y; Wang C; Dun J; Calvin Sun C
    Int J Pharm; 2023 Jun; 641():123041. PubMed ID: 37201765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On-Demand Manufacturing of Direct Compressible Tablets: Can Formulation Be Simplified?
    Azad MA; Osorio JG; Wang A; Klee DM; Eccles ME; Grela E; Sloan R; Hammersmith G; Rapp K; Brancazio D; Myerson AS
    Pharm Res; 2019 Oct; 36(12):167. PubMed ID: 31650274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and tableting of long-term stable amorphous rutin using porous silica.
    Wei Q; Keck CM; Müller RH
    Eur J Pharm Biopharm; 2017 Apr; 113():97-107. PubMed ID: 27847275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing challenges with solid dosage formulations containing vitamin E TPGS.
    Pandey P; Sinko PD; Bindra DS; Hamey R; Gour S; Vema-Varapu C
    Pharm Dev Technol; 2013 Feb; 18(1):296-304. PubMed ID: 23136832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal and Particle Engineering Strategies for Improving Powder Compression and Flow Properties to Enable Continuous Tablet Manufacturing by Direct Compression.
    Chattoraj S; Sun CC
    J Pharm Sci; 2018 Apr; 107(4):968-974. PubMed ID: 29247737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and evaluation of different mesoporous silica kinds as carriers for the development of effective oral dosage forms of glibenclamide.
    Mura P; Valleri M; Fabianelli E; Maestrelli F; Cirri M
    Int J Pharm; 2019 May; 563():43-52. PubMed ID: 30926527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High drug load, stable, manufacturable and bioavailable fenofibrate formulations in mesoporous silica: a comparison of spray drying versus solvent impregnation methods.
    Hong S; Shen S; Tan DC; Ng WK; Liu X; Chia LS; Irwan AW; Tan R; Nowak SA; Marsh K; Gokhale R
    Drug Deliv; 2016; 23(1):316-27. PubMed ID: 24853963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral hesperidin-Amorphization and improved dissolution properties by controlled loading onto porous silica.
    Wei Q; Keck CM; Müller RH
    Int J Pharm; 2017 Feb; 518(1-2):253-263. PubMed ID: 27871833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical method development for powder characterization: Visualization of the critical drug loading affecting the processability of a formulation for direct compression.
    Hirschberg C; Sun CC; Rantanen J
    J Pharm Biomed Anal; 2016 Sep; 128():462-468. PubMed ID: 27368089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S; Iwao Y; Kimura S; Itai S
    Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of direct compression powder blend transfer method from the container to the tablet press on product critical quality attributes: a case study.
    Teżyk M; Jakubowska E; Milczewska K; Milanowski B; Voelkel A; Lulek J
    Drug Dev Ind Pharm; 2017 Jun; 43(6):911-916. PubMed ID: 28032521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes.
    Kushner J; Langdon BA; Hicks I; Song D; Li F; Kathiria L; Kane A; Ranade G; Agarwal K
    J Pharm Sci; 2014 Feb; 103(2):527-38. PubMed ID: 24375069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
    Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
    Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical stability of high indomethacin payload ordered mesoporous silica MCM-41 and SBA-15 microparticles.
    Limnell T; Heikkilä T; Santos HA; Sistonen S; Hellstén S; Laaksonen T; Peltonen L; Kumar N; Murzin DY; Louhi-Kultanen M; Salonen J; Hirvonen J; Lehto VP
    Int J Pharm; 2011 Sep; 416(1):242-51. PubMed ID: 21763766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoding the small size challenges of mini-tablets for enhanced dose flexibility and micro-dosing.
    Mitra B; Thool P; Meruva S; Aycinena JA; Li J; Patel J; Patel K; Agarwal A; Karki S; Bowen W
    Int J Pharm; 2020 Jan; 574():118905. PubMed ID: 31809860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced oral delivery of celecoxib via the development of a supersaturable amorphous formulation utilising mesoporous silica and co-loaded HPMCAS.
    Lainé AL; Price D; Davis J; Roberts D; Hudson R; Back K; Bungay P; Flanagan N
    Int J Pharm; 2016 Oct; 512(1):118-125. PubMed ID: 27543354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.